All In Biotech

Drug Trial Radar · NCT07610564

A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy

An Open-Label, Single-Arm, Phase 1b Study to Evaluate the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jul 27, 2026

Primary completion

Feb 1, 2028

Study completion Apr 1, 2030

Sponsor

Lead sponsor
argenxargenx (ARGX)
Sponsor type
Industry
First posted
May 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of the study is to evaluate empasiprubart use in adults living with Multifocal Motor Neuropathy (MMN). The researchers will evaluate the effect of empasiprubart on the thickness of the nerves, muscle strength, movement, and on the potential improvement of grip strength of the participants in handling objects. The study consists of an open-label treatment period where all participants will receive empasiprubart intravenously (IV). After the last dose of empasiprubart participants will enter a safety follow-up period for up to 15 months. The total study duration for each participant will be approximately 29 months. More information can be found here: clinicaltrials.argenx.com/empasound

Conditions

  • Multifocal Motor Neuropathy (MMN)

Interventions

  • Empasiprubart IVBiological

    Intravenous infusions of empasiprubart

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in nerve CSA at week 24 as measured by ultrasound imaging of the median nerve and brachial plexus (individual nerves and average sum score)Time frame: Up to 48 weeks

Locations

5 sites in 2 countries. Site status is shown where the registry gives one.

  • Yale University School of Medicine

    New Haven, Connecticut · Recruiting

  • Aversi Clinic LTD

    Tbilisi, Georgia · Recruiting

  • Jo Ann Medical Center

    Tbilisi, Georgia · Recruiting

  • S. Khechinashvili University Clinic, Ltd.

    Tbilisi, Georgia · Recruiting

  • Pineo Medical Ecosystem

    Tbilisi, K'alak'i T'bilisi, Georgia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.